心房颤动筛查:对患者和医疗系统是负担还是获益
本文综述大规模试验和数字健康研究(包括可穿戴设备检测)的证据,指出心房颤动筛查可早期发现无症状房颤、及时启动口服抗凝并可能减轻卒中负担,但存在假阳性、不确定结果、不必要的随访检查、患者焦虑和资源压力等问题。通过靶向、技术增强的方法实施筛查可能使患者和医疗系统获益,但其总体价值取决于提高检出和改善临床结局与过度诊断、心理负担和系统成本之间的平衡。
要点
- 房颤是最常见的持续性心律失常,即使无症状也使缺血性卒中风险增加五倍。
- 早期发现并及时启动口服抗凝可显著降低卒中发生率,推动人群房颤筛查。
- 筛查的获益需与假阳性、过度诊断、焦虑和系统成本等风险平衡。
核心结论
- 通过靶向、技术增强的方法实施房颤筛查,有潜力通过预防卒中和优化资源使用使患者和医疗系统获益。
- 房颤筛查的总体价值取决于提高检出和改善临床结局与过度诊断、心理负担和系统成本之间的平衡。
- 房颤筛查的成功需要将新技术与循证照护路径仔细整合,以确保具有临床意义且可持续的医疗影响。
研究设计与样本
- 本文为综述,综合大规模试验和数字健康研究(包括基于可穿戴设备的检测)的结果。
主要发现
- 房颤是最常见的持续性心律失常,即使无症状也使缺血性卒中风险增加五倍。
- 早期发现和及时启动口服抗凝可显著降低卒中发生率。
- 筛查的获益包括更早诊断无症状房颤、及时治疗和可能减轻卒中负担。
- 筛查的缺点包括假阳性、不确定结果、不必要的随访检查、患者焦虑和资源压力。
- 新兴策略如人工智能引导的风险分层、改进的信号处理和整合的数字照护路径有望提高诊断准确性、减少误报警和简化临床管理。
临床怎么用
- 临床应考虑通过靶向、技术增强的方法实施房颤筛查,以平衡检出获益与过度诊断、心理负担和系统成本。
- 实施筛查时应整合人工智能风险分层、改进信号处理和数字照护路径,以提高诊断准确性并减少误报警。
- 筛查项目需与循证照护路径结合,确保临床意义和可持续的医疗影响。
局限性
- 筛查存在假阳性和不确定结果,可能导致不必要的随访检查。
- 筛查可能引起患者焦虑并增加资源压力。
- 筛查存在过度诊断、心理负担和系统成本的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Atrial fibrillation (AF) is the most common sustained arrhythmia and raises ischemic stroke risk fivefold, even when asymptomatic. Early detection and timely initiation of oral anticoagulation can significantly reduce stroke incidence, motivating interest in population-level AF screening. This review synthesizes findings from large-scale trials and digital health studies, including wearable device—based detection, and highlights both benefits and limitations of screening. Benefits include earlier diagnosis of silent AF, timely treatment, and potential reductions in stroke burden. However, drawbacks such as false positives, inconclusive results, unnecessary follow-up testing, patient anxiety, and resource strain remain important concerns. Emerging strategies—such as AI-guided risk stratification, improved signal processing, and integrated digital care pathways—offer promise in improving diagnostic accuracy, reducing false alarms, and streamlining clinical management. When implemented through targeted, technology-enhanced approaches, AF screening has the potential to benefit patients and healthcare systems by preventing strokes and optimizing resource use. However, its overall value depends on balancing improved detection and clinical outcomes against the risks of overdiagnosis, psychological burden, and system costs. Ultimately, the success of AF screening will require careful integration of novel technologies with evidence-based care pathways to ensure clinically meaningful and sustainable healthcare impact.
引用
- Journal of Cardiovascular Electrophysiology:Atrial Fibrillation Screening: Burden or Benefit for Patients and the Healthcare System
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。